AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Copernicus receives $1M from Cystic Fibrosis Foundation Therapeutics to advance development of a non-viral gene therapy for cystic fibrosis.
(From Chemical Business NewsBase - Press Release)
Copernicus Therapeutics Inc has received an extension to its therapeutics development award from Cystic Fibrosis Foundation Therapeutics Inc (CFF Therapeutics). This award in the amount of $750,000 was coupled with a $280,000 outstanding payment from the original therapeutics development award to bring the total payment to $1.03 M. The award extension is intended to support the Phase II advancement of Copernicus Therapeutics' potential genetic therapy for cystic fibrosis (CF). Copernicus Therapeutics' unique, non-viral nanoparticle formulation is intended to deliver a normal copy of the CF gene to the affected airway …
-
- Battling cystic fibrosis.(Cystic Fibrosis Foundation provides funds to...
-
Magazine article from: Philadelphia Business Journal
George, John
October 5, 2001
700+ words
-
- Hollis-Eden Pharmaceuticals and the Cystic Fibrosis Foundation to collaborate...
-
News wire article from: Asia Africa Intelligence Wire
June 18, 2003
700+ words
-
- Demegen Inc.(receives grant from Cystic Fibrosis Foundation Therapeutics...
-
Magazine article from: Pittsburgh Business Times
August 31, 2001
700+ words
-
- Cystic Fibrosis Foundation Offers Free Drugs to All Cystic Fibrosis Patients...
-
News wire article from: Europe Intelligence Wire
September 2, 2005
700+ words
-
- Cystic Fibrosis combines annual golf tournaments.(Cystic Fibrosis Foundation,...
-
Magazine article from: The Business Journal - Serving Phoenix & the Valley of the Sun
BALZER, STEPHANIE
October 29, 1999
700+ words
